EYE National Vision Holdings Company Projected Revenue

National Vision Holdings, Inc. - graphic logo of issuer EYE

National Vision Holdings (EYE) is expanding its network of ophthalmology centers by employing a deep-discount strategy for uninsured customers. The GURU.Markets portal provides this chart, where the company's projected sales level reaches 2.81. Stable demand for eyewear supports the business, while the digitalization of prescriptions and materials recycling minimize the company's environmental impact.

Company Revenue Forecast: America's Best Contacts & Eyeglasses (EYE) for 07/04/2022 - 11/18/2026

Analytical breakdowns for National Vision Holdings (EYE)

Fundamental valuation:National Vision EYE
Signature product of America's Best Contacts & Eyeglasses

The indicator is based on daily updates of consensus forecasts, which eliminates the time gap between quarterly reports and allows for a real-time assessment of the business's commercial potential. By analyzing the company's projected sales, an investor determines the extent to which expectations are priced in, which is critically important for National Vision Holdings (EYE) amid aggressive dumping by online retailers and the consolidation of the retail optics market.

Competing companies

Company Future Sales Volume HCA (HCA Inc.)|THC - Company Expected Sales Volume|Projected Sales Volume FMS (freseniusmedicalcare.com)|Solventum Inc. - Company Projected Revenue|EHC - Company Projected Revenue|Company Future Revenue UHS (Universal Health Services, Inc.)|DVA (DaVita) - Company Future Sales Volume|RDNT: Company Projected Revenue Volume|Company Future Sales Volume OPCH|Company Expected Sales Volume Surgery Partners, Inc. SGRY|Company Future Sales Volume PINC (Premier, Inc.)|PGNY (Progyny, Inc.) - Company Future Revenue|Projected Sales Volume ARDT (Ardent Health Corp)|SEM: Company Revenue Forecast|astranahealth.com - Projected Sales Volume|Company Expected Sales Volume Pediatrix Medical Group, Inc.|USPH: Projected Sales Volume|PNTG: Company Projected Revenue Volume|ORGO (Organogenesis Holdings Inc.) - Projected Sales Volume|NUTX: Company Future Revenue|Company Projected Revenue Auna Health (AUNA)|SBC (SBC Medical Group Holdings) - Company Future Revenue|Company Projected Revenue Evolus, Inc. EOLS|Company Projected Revenue Volume CYH (Community Health Systems)|SKIN - Company Projected Revenue|mediwound.com (MDWD) - Company Future Sales Volume|BTMD (biote Corp) - Company Future Sales Volume|JYNT: Company Projected Revenue Volume|DCGO (DocGo, Inc.) - Projected Sales Volume|Company Projected Revenue PIII|Company Future Sales Volume GANX (Gain Therapeutics, Inc.)|EUDA - Company Expected Sales Volume|Company Projected Revenue Basel Medical BMGL|CollPlant Biotechnologies (CLGN) - Company Expected Sales Volume|CUPR: Company Future Sales Volume|Company Future Sales Concord Medical Services CCM|AMS (American Shared Hospital) - Company Future Sales Volume|Company Revenue Forecast MRM|Company Projected Revenue avalon-globocare.com|Projected Sales Volume DIH Holding US Inc.|Company Projected Revenue Carmell Therapeutics (XAGE)|newgenivf.com - Company Revenue Forecast|Company Projected Revenue ATI Physical Therapy Inc. ATIP|CMAX: Company Revenue Forecast|kindlymd.com - Projected Sales Volume|Company Expected Sales Volume ModivCare Corp|NVOS (Novo Integrated Sciences) - Company Future Sales Volume|SunLink Health Systems Inc. - Company Future Revenue|Company Future Sales Volume BACK